Community-acquired Staphylococcus aureus bacteraemia in patients who do not abuse intravenous drugs

QJM: An International Journal of Medicine

Volumn 91, Issue 1, 1998, Pages 41-47

  Willcox, P A ^a   Rayner, B L ^a   Whitelaw, D A ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; CONFUSION; DIABETES MELLITUS; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOCARDITIS; FEMALE; FEVER; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHOOL CHILD; SHOCK; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; THROMBOCYTE COUNT;

EID: 0031975436     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.1.41     Document Type: Article

References (29)

1. Sheagren JN. Staphylococcus aureus. The persistent pathogen. N Engl J Med 1984; 310:1368-73.
2. Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn. Churchill Livingstone, 1995:1754-84.
3. Smith IM, Vickers AB. Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936-1955). Lancet 1960; 1:1318-22.
4. Jessen O, Rosendal K, Bülow P, Faber V, Eriksen KR. Changing staphylococci and staphylococcal infections: a ten-year study of bacteria and cases of bacteraemia. N Engl J Med 1969; 281:627-35.
5. Eykyn SJ. Staphylococcal sepsis. The changing pattern of disease and therapy. Lancet 1988; 1:100-4.
6. Gransden WR, Eykyn SJ, Phillips I. Staphylococcus aureus bacteraemia: 400 episodes in St Thomas's Hospital. Br Med J 1984; 288:300-3.
7. Powell DEB. Staphylococcal septicaemia in a general hospital. Br Med J 1961; 2:336-9.
8. Nolan CM, Beaty HN. Staphylococcus aureus bacteraemia. Current clinical patterns. Am J Med 1976; 60:495-500.
9. Fischer MJ, McArtor RE. Staphylococcal septicaemia. A study of one hundred cases. Ohio State Med J 1967; 63:1325-7.
10. Mukonyora M, Mabiza E, Gould IM. Staphylococcal bacteraemia in Zimbabwe 1983. J Infect 1985; 10:233-9.
11. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteraemia. Arch Intern Med 1984; 144:541-5.
12. Bayer AS, Lam K, Ginzton L, Norman DC, Chiu C-Y, Ward JI. Staphylococcus aureus bacteraemia. Clinical, serologic, and echocardiographic findings in patients with and without endocarditis. Arch Intern Med 1987; 147:457-62.
13. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteraemia. Rev Infect Dis 1987; 9:891-907.
14. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-74.
15. McCabe WR, Jackson GG. Gram negative bacteraemia 1. Etiology and ecology. Arch Intern Med 1962; 110:847-55.
16. Durack DT, Lukes AS, Bright DK and the Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilisation of specific echocardiographic findings. Am J Med 1994; 96:200-9.
17. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomised, double-blind, placebo-controlled trial. N Engl J Med 1991; 324:429-36.
18. Rayner BL, Willcox PA, Pascoe MD. Acute renal failure in community-acquired bacteraemia. Nephron 1990; 54:32-5.
19. Rayner BL, Willcox PA. Community-acquired bacteraemia; a prospective survey of 239 cases. Q J Med 1988; 69:907-19.
20. Verbrugh HA, van Dijk WC, Peters R, et al. Opsonic recognition of staphylocci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies. J Immunol 1980; 124:1167-73.
21. Kaplan MH, Tenenbaum MJ. Staphylococcus aureus: cellular biology and clinical application. Am J Med 1982; 72:248-58.
22. Whitelaw DA, Rayner BL, Willcox PA. Community-acquired bacteraemia in the elderly: a prospective study of 121 cases. J Am Geriatr Soc 1992; 40:996-1000.
23. Smith JA, O'Connor JJ, Willis AT. Nasal carriage of Staphylococcus aureus in diabetes mellitus. Lancet 1966; 2:776-7.
24. Tuazon CU, Perez A, Kishaba T, Sheagren JN. Staphylococcus aureus among insulin-injecting diabetic patients: an increased carrier rate. JAMA 1975; 231:1272.
25. Musher DM, Lamm N, Darouiche RO, Young EJ, Hamill RJ, Landon GC. The current spectrum of Staphylococcus aureus infection in a tertiary care hospital. Medicine 1994; 73:186-208.
26. Bryan CS, Kirkhart B, Brenner ER. Staphylococcal bacteremia: current patterns in non-university hospitals. South Med J 1984; 77:693-6.
27. Mirimanoff RO, Glauser MP. Endocarditis during Staphylococcus aureus septicaemia in a population of non-drug addicts. Arch Int Med 1982; 142:1311 -13.
28. Iannini PB, Crossley K. Therapy of Staphylococcus aureus bacteremia associated with a removable focus of infection. Ann Intern Med 1976; 84:558-60.
29. Frimodt-Moller N, Espersen F, Rosdahl VT. Antibiotic treatment of Staphylococcus aureus endocarditis. A review of 119 cases. Acta Med Scand 1987; 222:175-82.